Dr. Giuliano Testa is a graduate of the University of Padova Medical School in Italy. He completed General Surgery Residencies both at the University of Padova and at the University of Chicago and then a fellowship in Abdominal Organ Transplantation at Baylor University Medical Center in Dallas, Texas. In 1998 Dr. Testa moved to Germany to the University of Essen where he significantly contributed to start the Adult-to-Adult Living Donor Liver Transplant Program. In 2001, he was recruited with the title of Associate Professor of Surgery and Director of the Liver Transplant Program at the University of Illinois at Chicago. In 2005, he moved to the University of Chicago as Director of Liver Transplant and Hepatobiliary Surgery and rose to the rank of Professor of Surgery.

 

In 2008, Dr. Testa completed the Fellowship in Clinical Ethics at the MacLean Center for Clinical Ethics of the University of Chicago and joined the Faculty to become the Associate Director of the Surgical Ethics Program. In 2011 he obtained a Master’s Degree in Business Administration at the University of Chicago Booth School of Business.

 

Dr. Testa was recruited by Baylor University Medical Center in July 2011 to lead the Living Donor Liver Program. In 2017 he was promoted to Division Chief and in 2019 Chairman of the Simmons Transplant Institute.

 

Dr. Testa is actively involved in the American Society of Transplant Surgeons, where he currently is a member of the Living Donation Committee, in  the United Network for Organ Sharing (UNOS) where is currently serving on the Ethics Committee as well as on the Ethics Committee at Baylor University Medical Center. Dr Testa is Board Member of the American Society of Reconstructive Transplantation and Founding Member of the International Society of Uterus Transplantation and the United States Uterus Transplant Consortium.

 

Dr. Testa is author or co-author of more than 170 manuscripts and several book chapters. He is a recognized authority in the field of Living Donor Liver Transplantation, Living Donor Intestinal Transplantation and Uterus Transplantation.